Ali Nagwa M, Ibrahim Mohammed O, Mohamed Osama M
Rheumatology, Mediclinic Airport Road Hospital, Abu Dhabi, ARE.
Clinical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, ARE.
Cureus. 2025 Jul 13;17(7):e87858. doi: 10.7759/cureus.87858. eCollection 2025 Jul.
Adult-onset Still's disease (AOSD) is a rare autoinflammatory disorder characterized by high spiking fevers, salmon-colored rash, arthritis, and hyperferritinemia. It often mimics infections or autoimmune conditions, leading to diagnostic delays. We report a case of a 49-year-old female who presented with fever, fatigue, arthralgia, evanescent rash, and elevated inflammatory markers. Extensive infectious and autoimmune workups were negative. Her serum ferritin exceeded 16,000 ng/mL. She fulfilled the Yamaguchi criteria for AOSD, and treatment with corticosteroids followed by tocilizumab resulted in marked clinical improvement. This is, to our knowledge, the first documented case of AOSD from the UAE. It underscores the importance of ferritin in diagnosis and disease monitoring and highlights the efficacy of interleukin (IL)-6 inhibition in management.
成人斯蒂尔病(AOSD)是一种罕见的自身炎症性疾病,其特征为高热、鲑鱼色皮疹、关节炎和高铁蛋白血症。它常表现类似感染或自身免疫性疾病,导致诊断延迟。我们报告一例49岁女性病例,该患者出现发热、疲劳、关节痛、一过性皮疹和炎症标志物升高。广泛的感染和自身免疫检查均为阴性。她的血清铁蛋白超过16,000 ng/mL。她符合AOSD的山口标准,使用皮质类固醇随后使用托珠单抗治疗后临床症状显著改善。据我们所知,这是阿联酋第一例有记录的AOSD病例。它强调了铁蛋白在诊断和疾病监测中的重要性,并突出了白细胞介素(IL)-6抑制在治疗中的疗效。